viking oral glp 1 Therapeutics Announces Results from Phase Clinical Trial of Tablet Formulation of Dual GLP-1/GIP Receptor Agonist VK2735 Viking's stock plummets on obesity
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2


























